In our modern health care landscape, comparative effectiveness research and evidence-based treatment for autism spectrum disorder (ASD) devotes a great amount of time, effort, and money to interventions for children. While clearly interrelated, the progress made in the realm of childhood autism, which includes new studies and support tools, seems to disappear as those children transition into adulthood, leaving a hole in policy and coverage even as research finds ASD prevalence roughly the same in both the adult and child populations (see British Survey Shows Autism . . .